NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, announced that Mark L. Weinstein, President and Chief Executive Officer will be presenting at the UBS 22nd Annual Global Healthcare Services Conference in New York City on Tuesday, February 7, 2012 at 4:00 p.m. EST.
